Company: INMB
Filing Date: 2025-05-09
Form Type: DEFR14A
Source: 0001213900-25-041516
Chunk: 7

Company: Inmune Bio, Inc.
Filing Date: 2025-05-09
Form: DEFR14A
Chunk 7
---
 policies, the activities of our internal audit function, and information technology. |

The Board of Directors has affirmatively determined
that each member of the audit committee meets the additional independence criteria applicable to audit committee members under SEC rules
and the Nasdaq Stock Market LLC. The Board of Directors has adopted a written charter setting forth the authority and responsibilities
of the audit committee. The Board of Directors has affirmatively determined that each member of the audit committee is financially literate,
and that all members meet the qualifications of an audit committee financial expert. The audit committee consists of Timothy Schroeder,
Scott Juda, J.D., and Marcia Allen. Scott Juda, J.D., is the chairman of the audit committee.

Based on their review, the audit committee recommended
to the Board of Directors that the audited financial statements be included in the Company’s Annual Report on Form 10-K for
the year ended December 31, 2024 for filing with the SEC.

Required Stockholder Vote and Recommendation of Our Board of Directors

Approval of our independent registered public
accounting firm requires the affirmative vote of a majority of the votes cast at the Meeting, whether in person or by proxy, provided
that a quorum is present. An abstention will not be counted for or against the proposal, and therefore will not affect the vote outcome.

<div align='center'>OUR BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE
“ FOR” THE RATIFICATION OF CBIZ CPAs P.C. AS OUR INDEPENDENT REGISTERED ACCOUNTING FIRM FOR OUR FISCAL YEAR ENDED DECEMBER 31, 2025.

5</div>